Zhavoronkov points to an analysis across major semaglutide trials and says the later effects on organ aging are only partly explained by weight loss.
Recap by typeshit. Post by Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs) on X.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
In rats and minipigs, doses too small to cut weight still reduced heart scarring and stiffness tied to a common heart failure type, researchers report.
German researchers made synthetic versions of peptides from axolotl skin mucus, and some slowed the growth of MRSA, the drug-resistant bacteria.
10:45
The nutrition and exercise graduate walks through her food picks for people on retatrutide, aimed at holding onto muscle during weight loss.
Experts say holding on to weight loss after quitting a GLP-1 is possible and walk through the habits they recommend for the transition.
A fresh warning points to more people ending up in hospital after taking peptides that aren't approved. Tap through for who issued it.
Loading…